Evidence map›Paper›PMID 27831551›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2017

Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014.

K A Ahmad, S J Desai, M M Bennett, S F Ahmad, Y-T Ng, R H Clark, V N Tolia

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Association between anti-seizure medication and outcomes in infants.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  9. Article
  10. Novel Therapeutics for Neonatal Seizures.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  11. Neonatal Seizures Revisited.Children (Basel, Switzerland) · 2021
    Review
  12. Review
  13. Review of Drug Utilization Studies in Neonatal Units: A Global Perspective.International journal of environmental research and public health · 2020
    Review
  14. Review
  15. Neurodevelopmental outcomes at 9-14 months gestational age after treatment of neonatal seizures due to brain injury.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2019
    Article
  16. Article
  17. Status Epilepticus in the Neonate: Updates in Treatment Strategies.Current treatment options in neurology · 2019
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

K A AhmadPediatrix Medical Group, San Antonio, TX, USA.
S J DesaiPediatrix Medical Group, Austin, TX, USA.
M M BennettOffice of The Chief Quality Officer, Baylor Scott & White Health, Dallas, TX, USA.
S F AhmadDepartment of Pediatrics, Baylor College of Medicine, San Antonio, TX, USA.
Y-T NgDepartment of Pediatrics, Baylor College of Medicine, San Antonio, TX, USA.
R H ClarkPediatrix Medical Group, Sunrise, FL, USA.
V N ToliaPediatrix Medical Group, Dallas, TX, USA.
Baylor College of Medicine · USBaylor Scott & White Health · USBaylor University Medical Center · USSunrise Medical (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNeonatal seizures are a common problem in the neonatal intensive care unit and are frequently treated with antiepileptic drugs. Limited data exist on current or changing antiepileptic drug use for seizures in the neonatal intensive care unit.We sought to describe trends of antiepileptic drug exposure in a large volume of US neonatal intensive care unit from 2005 to 2014 and we hypothesized increasing levetiracetam exposure over the 10-year study period. STUDY

designRetrospective cohort study of infants from the Pediatrix Medical Group Clinical Data Warehouse, a large, multicenter, deidentified data set. Data were analyzed for trends in 2-year time periods. Our cohort included infants with a diagnosis of seizures who received an antiepileptic drug that were discharged from the neonatal intensive care unit from 1 January 2005 to 31 December 2014.

resultsAmong 778 395 infants from 341 facilities, we identified 9134 infants with a seizure diagnosis who received an antiepileptic drug. Phenobarbital was used in 98% of the cohort. From 2005-2006 to 2013-2014 phenobarbital exposure declined from 99 to 96% (P<0.001), phenytoin exposure decreased from 15 to 11% (P<0.001) and levetiracetam exposure increased 10-fold from 1.4 to 14% (P<0.001). Overall, <1% of infants were exposed to carbamazepine, lidocaine or topiramate.

conclusionsInfants with seizures were overwhelmingly exposed to phenobarbital, despite a significant increase in levetiracetam exposure. The use of phenytoin declined and has been surpassed by levetiracetam as the second most widely used antiepileptic in the neonatal intensive care unit. These changes in antiepileptic drug usage patterns have occurred in the absence of novel efficacy data in neonates.

Indexed as

AnticonvulsantsChildDrug UtilizationFemaleHumansInfantInfant, NewbornIntensive Care Units, NeonatalLevetiracetamMalePhenobarbitalPhenytoinPiracetamRetrospective StudiesSeizuresTexasAnticonvulsantsLevetiracetamPhenobarbitalPhenytoinPiracetam

Identifiers

PMID27831551
OpenAlexW2550501788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.